Fondazione Salvatore Maugeri-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2016

  1. Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trial

    Journal of Clinical Oncology, Vol. 34, Núm. 14, pp. 1601-1610

2012

  1. Pathological complete response rates following different neoadjuvant chemotherapy regimens for Operable Breast Cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II)

    Breast Cancer Research and Treatment, Vol. 132, Núm. 3, pp. 843-851